Anocca Raises $47M to Advance TCR-T Cellular Immunotherapy
Financing from renowned Nordic investors Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics for cancer, today announced the...
Category : Clinical Intelligence/Clinical Efficiency
Clinical Intelligence Co. Pfizer Announces Investor Relations Leader
Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior Vice President and Chief Investor Relations Officer, reporting to Chief...
Celltrion’s Results on Monoclonal Antibody Treatment for COVID-19
 Pre- clinical data for regdanvimab (CT-P59) demonstrates strong neutralising activity against the Delta variant (B.1.617.2, first identified in India); results show 100% survival rate with...
Wugen Raises $172 Million for Clinical Stage Memory NK Cell Platform
Proceeds to advance clinical development of WU-NK-101 for relapsed/refractory AML, and initiate studies in solid tumor indications — Oversubscribed Series B co-led by Abingworth and...
Ribon Therapeutics Secures $65 Million Financing
Proceeds Support Advancement of Lead Product Candidates RBN-2397 and RBN-3143 Through Key Clinical Milestones Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress...
Castor Raises $45M Series B to Modernize Clinical Trial Process
Castor, a leading provider of clinical trial software, announced today the closing of a $45 million Series B financing round, bringing the company’s total funding...
Nimbus Therapeutics Raises $105 Million to Advance Clinical Programs
Multiple Phase 2 studies of allosteric TYK2 inhibitor in 2021 and 2022 will investigate ‘pipeline-in-a-product’ potential – Financing will also support first-in-human trial of HPK1...
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates Exscientia has received a grant from...
4G Clinical Announces $230M Growth Equity Investment
The innovative RTSM leader grew over 100% in 2020, plans to accelerate global expansion and support critical demand for products and services 4G Clinical, a...
Apervita Uses Carta Healthcare’s AI-Driven Clinical Data Abstraction
Addition of technology to save clinicians hours manually documenting quality measurement data Apervita, the trusted platform for healthcare collaboration, today announced that it has added Carta Healthcare’s artificial...